DCGI opens up to public grievances

Continuing with its efforts to become more accessible to different stakeholders, the Drugs Controller General of India has deputed senior officers to handle concerns related to clinical trials or other issues


DCGI's office has been often at the receiving end of criticism on the lack of a two way communication.

In a notification issued on July 07, 2014, the Drugs Controller General of India (DCGI) office has mentioned that it intends to address the grievances of the public and those concerned in a systematic manner.

The notice was in continuation with the office order number DCGI/Misc/2014  dated 25 June 2014 with respect to public issues.

Mr Aseem Sau, deputy drugs controller general of India, would be now available in Room no.1 in FDA Bhavan from Monday to Friday along with Mr Kasi Venugopal and Mr Dinesh Kumar, drug inspectors, to recieve the public complaints and listen to the issues.

The appellants can give their statement in writing along with the relevant documents for further action.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email